(Q40310685)

English

Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin

scientific article published on 27 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Alice M Sorrell

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

John H Shand

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Elizabeth Tonner

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Matteo Gamberoni

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pier A Accorsi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

James Beattie

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gordon J Allan

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

David J Flint

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

27 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

281

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

10883-10889

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Growth hormone, acting in part through the insulin-like growth factor axis, rescues developmental, but not metabolic, activity in the mammary gland of mice expressing a single allele of the prolactin receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

A quantitative RT-PCR study of the mRNA expression profile of the IGF axis during mammary gland development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The role of stasis in the clotting of blood and milk flows around solid objects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Cell migration: interactions among integrins, IGFs and IGFBPs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508505200

21 January 2018

Identifiers

10.1074/JBC.M508505200

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40310685&oldid=1894983837"